Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response. The study appeared in the online issue of Oncogene. The IKBKE gene i more
To use all functions of this page, please activate cookies in your browser.